|
Mukhamadieva V.N., Shamsutdinova N.G., Abdulganieva D.I., Abdrakipov R.Z.,Mukhina R.G., Dyakova E.V., Sukhorukova E.V.
Peculiarities of COVID-19 clinical course in patients with various rheumatic diseases
|
№7 / 2023
|
|
Bolieva L.Z., Malyavin A.G., Vyalkova A.B.
Persistent viral shedding of SARS-CoV-2 in pathogenesis of Long-COVID-19
|
№10 / 2022
|
|
Trofimov N.A., Tarasova L.V., Dimitrieva O.V., Babokin V.E., Dubova A.V.
Assessment of the clinical course and outcomes of COVID-19 in vaccinated patients
|
№8 / 2022
|
|
Pilat T.L., Kuzmina L.P., Lazebnik L.B., Khanferyan R.A.
Peculiarities of dietary therapeutic food for COVID-19 with gastrointestinal tract damage
|
№7 / 2022
|
|
Korshunova A.A., Kulikov A.N., Trofimov V.I., Teplov V.M., Kovalchuk Yu.P., Kadinskaya M.I., Ginzburg A.M., Lapin S.V.
Prognostication of thrombotic and hemorrhagic events in patients hospitalized with novel coronavirus infection COVID-19
|
№6 / 2022
|
|
Bolieva L.Z., Malyavin A.G., Ovsyannikova A.I.
Invasive fungal infections in patients with COVID-19
|
№5 / 2022
|
|
Babak S.L., Gorbunova M.V., Goruleva E.I., Malyavin A.G.
Nebulized budesonide in asthma exacerbations: rules of therapy in the COVID-19 era
|
№5 / 2022
|
|
Ovsyannikov E.S., Feygelman S.N., Alexeeva N.G.
On the issue of cough treatment in COVID-19 patients
|
№4 (приложение) / 2022
|
|
Gomon Yu.M., Kolbin A.S., Strizheletsky V.V., Ivanov I.G., Sultanova F.M., Balykina Yu.E., Verbitskaya E.V.
A systematic review with meta-analysis of the safety of Janus kinase inhibitors in relation to the risks of secondary bacterial infections
|
№4 / 2022
|
|
Bolieva L.Z., Malyavin A.G., Aidarova N.K., Byazrova S.S.
Multisystem inflammatory syndrome in adults associated with COVID-19
|
№3 / 2022
|
|
Mubarakshina O.A.
Possibilities of treatment of patients with physiological and functional pulmonary deficiency symptoms after previous COVID-19 infection (review of the symposium with international participation at the XXXI National Congress on Respiratory Diseases)
|
№10 / 2021
|
Русский
